For research use only. Not for therapeutic Use.
Nadolol-d9 (CAS: 94513-92-5), a premium pharmaceutical research compound designed for advanced cardiovascular and antihypertensive studies. As a deuterated analog of Nadolol, it offers enhanced stability and improved pharmacokinetic properties. Nadolol-d9 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for hypertension and heart disease. Trusted by leading laboratories, Nadolol-d9 is your go-to solution for cutting-edge cardiovascular research. Unlock new possibilities in blood pressure and heart disease treatment with Nadolol-d9, where innovation meets reliability.
| Catalog Number | S000159 |
| CAS Number | 94513-92-5 |
| Molecular Formula | C17H18D9NO4 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| IUPAC Name | 5-[3-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol |
| InChI | InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/i1D3,2D3,3D3 |
| InChIKey | VWPOSFSPZNDTMJ-GQALSZNTSA-N |
| SMILES | [2H]C([2H])([2H])C(C([2H])([2H])[2H])(C([2H])([2H])[2H])NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O |
| Reference | [1]. Johannes C von Alvensleben, et al. Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children. Pediatr Cardiol. 2017 Mar;38(3):525-530. |
